In this study, caspase-3 overexpression was observed when comparing the tumor-bearing untreated control (G3) with G7 and G9 (tumor-bearing group treated with liposomes subcutaneously administered with 30 mg and 15 mg of lunasin/kg BW, respectively) (p < 0.05) (Figure 5B). Here, CASP3 is linked to neoplasm.